There is a temptation, in any fast-moving market, to treat compliance as a tax — a cost to be minimized on the way to growth. In diagnostics, that gets the economics exactly backwards.
When a lab, a payer or a screening program builds on an infrastructure partner, they are extending their own regulatory perimeter to include that partner. Every kit, every shipment, every electronic record becomes part of their audit trail. They cannot afford to build on a foundation they can't stand behind. Which means, counter-intuitively, that the depth of your compliance is a sales advantage — not a drag on it.
The map that matters
RDi USA's quality and security systems are certified to international standards and mapped deliberately onto the US framework:
- ISO 13485 → supports FDA Quality System Regulation (21 CFR Part 820)
- ISO 27001 → underpins enterprise information security
- 21 CFR Part 11-ready → electronic records and signatures, via +CURA
- CLIA-aware workflows and UN3373 shipping across the network
You don't re-earn trust program by program. It's built into the infrastructure, once, and inherited by everything on top.
Why it compounds
A compliance moat gets deeper with scale. Each certification, each audit passed, each program delivered without incident makes the next customer's decision easier and the next competitor's job harder. It is one of the few advantages in this industry that cannot be bought quickly — only built, patiently, and proven over time.
RDi USA is working towards the full set of US standard requirements as it scales, and treats that work not as a checkbox but as the product itself.